Table: Mochida Pharm -2025/26 group results

Mochida Pharmaceutical Co

15/05/2026 06:00

May 15 (Reuters)- 
          Mochida Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          116.95          105.16         126.00                 
               (+11.2 pct)     (+2.2 pct)     (+7.7 pct)               
  Operating       10.15            8.13          10.50                 
               (+24.9 pct)     (+40.1 pct)    (+3.5 pct)               
  Recurring       11.20            8.07          12.50                 
               (+38.8 pct)     (+33.6 pct)    (+11.6 pct)              
  Net
  Net              7.90            5.69          10.00                 
               (+39.0 pct)     (+25.0 pct)    (+26.5 pct)              
  EPS          222.96 yen      160.36 yen     282.09 yen               
  Ann Div       80.00 yen       80.00 yen      85.00 yen               
  -Q2 Div       40.00 yen       40.00 yen      42.50 yen               
  -Q4 Div       40.00 yen       40.00 yen      42.50 yen               
  
  NOTE - Mochida Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T